We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with uncontrolled gout had additional burdens ...

Patients with gout are more likely than those without to initiate chronic opioid use. Patients with gout are more likely than those without to initiate chronic opioid use, according to study results ...

BLOOM (TAMPA) – Nephrologist Jason B. Rothschild, MD, recently joined Gayle Guyardo, the host of the globally syndicated health and wellness show Bloom, to discuss the often-overlooked connection ...

In July 2022, the US Food and Drug Administration (FDA) expanded the labeling of Krystexxa (pegloticase; Horizon Therapeutics), a PEGylated uric acid-specific enzyme, to include coadministration with ...

The MarketWatch News Department was not involved in the creation of this content. -- Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Although rare, hypercalcemia should be treated as a potential threat for patients with from ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

Veterans with gout were 30% more likely to be prescribed chronic opioid therapy than those without gout, with factors such as female sex, underweight BMI, current smoking status, and a higher burden ...

TikTok is overflowing with videos promising to “flush” uric acid, reverse gout overnight, or cure joint pain with a single ...

JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic ...

A major international study has found gout is a chronic illness where genetics is a major cause, rather than lifestyle choices of the sufferer. Led by University of Otago researchers, the genome-wide ...

Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients with mild to moderate renal impairment, showed the URAT1 inhibitor lowered serum uric ...